Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension, July 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 69 articles: HTML format

Single Articles

1. WANG Y, Wang X, Zhang Y, Lin L, et al
   Molecular mechanisms of EPAS1 in regulating pulmonary vascular remodeling in COPD: a review.
   Mol Biol Rep. 2026;53:1092.
   PubMed    
   Abstract available
   
   

2. WANG J, Xi L, Tao X, Li H, et al
   Evaluation of Pulmonary Artery Flow Reserve in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Pilot Study.
   J Am Heart Assoc. 2026 Jul 3:e047624. doi: 10.1161/JAHA.125.047624.
   PubMed    
   Abstract available
   
   

3. GOZDECKI L, Belkin MN
   Picking Up the Tempo on Treatment of Combined Post- and Pre-capillary Pulmonary Hypertension: Viewpoint on the CADENCE Trial.
   US Cardiol. 2026;20:e11.
   PubMed    
   
   
   

4. DUSIK M, Havranek S, Fingrova Z, Jansa P, et al
   Long-term follow-up of patients with pulmonary hypertension after catheter ablation of atrial fibrillation and atrial tachycardia.
   Front Cardiovasc Med. 2026;13:1826752.
   PubMed    
   Abstract available
   
   

5. LI T, Zhang S, Aluquin V, Donnelly A, et al
   Early Tracheal and Salivary miRNAs in Extremely Preterm Infants Predict BPD-related Pulmonary Hypertension.
   bioRxiv [Preprint]. 2026 Jun 23:2026.06.17.732493.
   PubMed    
   Abstract available
   
   

6. CLINTON IW, Coursen JC, Rosen DT, Suresh K, et al
   Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary Hypertension.
   bioRxiv [Preprint]. 2026 Jun 22:2026.06.16.732773.
   PubMed    
   Abstract available
   
   

7. IKEDA N, Iijima R, Hara H
   Retrograde Balloon Pulmonary Angioplasty for Otherwise Uncrossable Lesions in Chronic Thromboembolic Pulmonary Hypertension.
   Catheter Cardiovasc Interv. 2026 Jul 2. doi: 10.1002/ccd.70725.
   PubMed    
   Abstract available
   
   

8. 
   Correction to "Lycopene Ameliorates Hypoxic Pulmonary Hypertension via Suppression of Oxidative Stress".
   Oxid Med Cell Longev. 2026;2026:e9847903.
   PubMed    
   
   
   

9. GONG LJ, Huang W, Zheng RX, Zhang Y, et al
   [Junren Bufei Yixin Granules ameliorates hypoxic pulmonary hypertension by regulating RELM-beta/SLC7A11/GPX4 signaling pathway].
   Zhongguo Zhong Yao Za Zhi. 2026;51:2588-2599.
   PubMed    
   Abstract available
   
   

10. WANG D, Huang N, Cai M, Huang R, et al
    Corrigendum to "Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis" [Toxicology and Applied Pharmacology 507 (2026) 117657].
    Toxicol Appl Pharmacol. 2026 Jul 2:117932. doi: 10.1016/j.taap.2026.117932.
    PubMed    
    
    
    

11. WILSON WM, Aldweib N, Celermajer DS, Opotowsky AR, et al
    Pulmonary Hypertension in Adults With a Systemic Right Ventricle (Biventricular Circulation).
    JACC Adv. 2026;5:102974.
    PubMed    
    Abstract available
    
    

12. ROJAS CHAVERRA IC, Poveda Conde LC, Acosta Pelaez JD, Fernandez Velez FR, et al
    Giant Pulmonary Artery Aneurysm in Chronic Thromboembolic Pulmonary Hypertension: Multimodality Imaging of a Rare Complication.
    JACC Case Rep. 2026 Jul 2:109129. doi: 10.1016/j.jaccas.2026.109129.
    PubMed    
    Abstract available
    
    

13. TAMURA Y, Kusunose K, Yamashita Y, Akagi T, et al
    JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis.
    Circ J. 2026 Jun 30. doi: 10.1253/circj.CJ-25-1144.
    PubMed    
    
    
    

14. TRAN HV, Van Dreumel C, Schafer A, Mukherjee M, et al
    Blood Pressure Change After Six-minute Walk Test Is an Independent Predictor of Clinical Worsening in Patients with Pulmonary Hypertension.
    Ann Am Thorac Soc. 2026 Jul 1:aaoag178. doi: 10.1093.
    PubMed    
    
    
    

15. ABUSIDO T, Alshaibi S, Aldraihem A, Alfadhel A, et al
    Late presentation of alveolar capillary dysplasia with misalignment of pulmonary veins presenting as refractory pulmonary hypertension in infancy.
    Respir Med Case Rep. 2026;62:102456.
    PubMed    
    Abstract available
    
    

16. HA MN, Thuillet R, Ottaviani M, Normand C, et al
    Placental Growth Factor Promotes Endothelial Activation and Inflammatory Remodelling in Pulmonary Hypertension.
    Cardiovasc Res. 2026 Jul 1:cvag147. doi: 10.1093.
    PubMed    
    Abstract available
    
    

17. VOLKOV AV, Yudkina NN, Nikolaeva EV, Nasonov EL, et al
    [Initial disorders of pulmonary hemodynamics in patients with systemic sclerosis: the relevance of the new hemodynamic definition of pulmonary arterial hypertension].
    Ter Arkh. 2026;98:275-281.
    PubMed    
    Abstract available
    
    

18. MAHASHABDE ML, Guniganti SK, Saketh BVN
    Perfect diagnostic accuracy in a small derivation cohort and outdated classification criteria: Methodological concerns regarding miR-21 as a biomarker for chronic obstructive pulmonary disease-associated pulmonary hypertension.
    Lung India. 2026;43:481-482.
    PubMed    
    
    
    

19. JIANG XH, Yang YH, Yang SQ, Guo XJ, et al
    [Dyspnea, pulmonary mosaic sign and pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:762-767.
    PubMed    
    Abstract available
    
    

20. QIAN J, Song C, Yuan M, Bai Y, et al
    Integrated Mindfulness and Cardiopulmonary Rehabilitation Improves Cardiopulmonary Performance and Psychological Stress in Pulmonary Arterial Hypertension.
    Can Respir J. 2026;2026:e3058088.
    PubMed    
    Abstract available
    
    

21. KAGAMI K, Yuasa N, Harada T, Tani Y, et al
    Echocardiography-Derived Exercise Pulmonary Hypertension and Longitudinal Changes in Pulmonary Artery Pressures in Systemic Sclerosis: A Non-Invasive Assessment for Risk Stratification.
    Pulm Circ. 2026;16:e70282.
    PubMed    
    Abstract available
    
    

22. WANG DW, Katayama A, Ligon MM, Crowley SE, et al
    Incidence of Adverse Cardiac Events After Liver Transplantation in Patients With Different Hemodynamic Classifications of Pulmonary Hypertension.
    Int J Hepatol. 2026;2026:2869285.
    PubMed    
    Abstract available
    
    

23. SALEEMI S, Alameer R, Alsulaim T, Alghasab N, et al
    Prevalence of Anxiety and Depression in Patients With Pulmonary Hypertension and Their Impact on Health-Related Quality of Life: A Prospective Cross-Sectional Observational Study.
    Cureus. 2026;18:e109819.
    PubMed    
    Abstract available
    
    

24. CHEN R, Chen X, Liang L, Li H, et al
    HO-1-modified umbilical cord MSCs alleviate pulmonary arterial hypertension by reducing inflammation and endothelial dysfunction.
    Stem Cells Transl Med. 2026;15:szag036.
    PubMed    
    Abstract available
    
    

25. SPERRY BW, Carlino I, Palazzuoli A
    Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.
    Heart Fail Rev. 2026;31:76.
    PubMed    
    Abstract available
    
    

26. FENG H, Liu Y, Hu W, Zou J, et al
    IL-22BP attenuates right ventricular remodeling in pulmonary arterial hypertension.
    Clin Sci (Lond). 2026;140:1575-1597.
    PubMed    
    Abstract available
    
    

27. PALMERT T, Hui W, Simpkin CT, Dragulescu A, et al
    Association between hepatic vein Doppler and echocardiographic diastolic indices with invasively measured right ventricular filling pressures in pediatric pulmonary arterial hypertension.
    Int J Cardiol. 2026;460:134619.
    PubMed    
    Abstract available
    
    

28. BLAKE MJ, Prins SE, Blake J, Hartweck LM, et al
    Pulmonary arterial hypertension induces a metabolic and inflammatory hepatopathy.
    J Clin Invest. 2026;136:e201862.
    PubMed    
    Abstract available
    
    

29. LI M, Wang Y, Hu X, Zhao H, et al
    Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children.
    BMC Pediatr. 2026;26:601.
    PubMed    
    Abstract available
    
    

30. CHEN J, Chen W, Li Z, Luo J, et al
    Prognostic significance of circulating level of GRP78 in pulmonary arterial hypertension.
    BMC Cardiovasc Disord. 2026;26:513.
    PubMed    
    Abstract available
    
    

31. GAO X, Yang Y, Guo L, Wang L, et al
    TCONS_00052110 is associated with prolonged PTBP1 half-life and mitochondrial injury in PAH-associated right ventricular stress.
    Sci Rep. 2026;16:19892.
    PubMed    
    Abstract available
    
    

32. IKWUANUSI E, Rajah T, Scandrett K, Asamane EA, et al
    Perioperative management of pulmonary arterial hypertension in children undergoing congenital heart surgery: a systematic review and meta-analysis.
    J Cardiothorac Surg. 2026;21:420.
    PubMed    
    Abstract available
    
    

33. CHEN L, Wang C, Li J, Lv L, et al
    Pulmonary arterial hypertension caused by compression of the left lower pulmonary vein in children.
    J Cardiothorac Surg. 2026;21:376.
    PubMed    
    Abstract available
    
    

34. ZHENG YM, Jiang JQ, Li X, Huang HB, et al
    Novel KCNK3 variant in a child with pulmonary arterial hypertension.
    Hereditas. 2026;163:67.
    PubMed    
    Abstract available
    
    

35. SALIK DEMIRTAS N, Loku E, Porschen Y, Schaffer J, et al
    Hypoxia or tobacco-smoke exposure induce region-specific microvascular remodeling in the brain.
    Sci Rep. 2026;16:12722.
    PubMed    
    Abstract available
    
    

36. CARMONA-SEGOVIA AD, Morales-Asencio JM, Escribano-Subias P, Rodriguez-Capitan J, et al
    Quality of life in patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
    Health Qual Life Outcomes. 2026;24:76.
    PubMed    
    Abstract available
    
    

37. SHINYA Y, Hiraide T, Momoi M, Goto S, et al
    Experimental pulmonary arterial hypertension in mice with a pathogenic SOX17 variant.
    Sci Rep. 2026;16:16168.
    PubMed    
    Abstract available
    
    

38. BARBOSA VM, Santos RT, Dos Santos de Assumpcao L, Correa AMC, et al
    Neuroinflammation, blood-brain barrier dysfunction, and cognitive decline in pulmonary arterial hypertension: an experimental study.
    Sci Rep. 2026;16:17251.
    PubMed    
    Abstract available
    
    

39. CHEN K, Li Z, Lu J, Guo Y, et al
    Activation of alpha7nAChR prevents maladaptive right ventricular remodeling via inhibiting the recruitment of CCR2(+) macrophages in experimental pulmonary arterial hypertension.
    Respir Res. 2026;27:206.
    PubMed    
    Abstract available
    
    

40. HU B, Chen S, Dong L
    The mechanism of S100A4 regulating Fibulin-5 expression to promote the proliferation and migration of PASMCs.
    Sleep Breath. 2026;30:116.
    PubMed    
    Abstract available
    
    

41. QIAN Z, Kan J, Chen Y, Ye P, et al
    CircATXN2 exacerbates pulmonary arterial hypertension by modulating the miR-138-5p/SMURF1 axis.
    Respir Res. 2026;27:203.
    PubMed    
    Abstract available
    
    

42. GAO S, Zhao S, Wang Y, Liu Y, et al
    CHI3L1: a novel regulator of vascular remodeling in pulmonary arterial hypertension.
    Mol Cell Biochem. 2026;481:2063-2081.
    PubMed    
    Abstract available
    
    

43. GENG X, Wang Z, Liu Y, Zhu J, et al
    Construction and validation of high altitude pulmonary edema prediction models based on deep learning and quantitative analysis of X-ray images.
    BMC Med Imaging. 2026;26:235.
    PubMed    
    Abstract available
    
    

44. NASIR M, Markos S
    Survival and mortality predictors among adults with rheumatic heart disease in ethiopia: a 10-year retrospective cohort study.
    BMC Cardiovasc Disord. 2026;26:383.
    PubMed    
    Abstract available
    
    

45. ENGOLE YM, Makanzu B, Mvunzi TS, Makulo JR, et al
    Elevated tricuspid regurgitation velocity in adults with sickle cell disease and HbAA controls in Kinshasa, Democratic Republic of the Congo: a comparative cross-sectional study.
    Ann Hematol. 2026;105:192.
    PubMed    
    Abstract available
    
    

46. WANDE Y, Qianqian C, Yi W, Minghui Z, et al
    S- nitrosylation of Annexin A2 at Cys133 ameliorates pulmonary arterial hypertension by inhibiting the WNT/beta-catenin pathway.
    Respir Res. 2026;27:217.
    PubMed    
    Abstract available
    
    

47. UYANER KAN M, Kan H, Alsancak Y, Alkan Baylan F, et al
    Mitral stenosis severity and the hypoxic response: potential role of hypoxia-inducible factor-2alpha - a cross-sectional study.
    BMC Cardiovasc Disord. 2026;26:348.
    PubMed    
    Abstract available
    
    

48. PALMERI S, Lancieri M, Ferro J, Salvati P, et al
    Efficacy of combined JAK1/2 inhibition and cyclosporine in paediatric-onset Still's disease with lung involvement: a case report.
    Pediatr Rheumatol Online J. 2026;24:27.
    PubMed    
    Abstract available
    
    

49. RATTANATHANYA H, Binetti A, Pohlin F, Ferreira SCM, et al
    Cardiovascular effects of a selective 5-HT4 agonist and an alpha-2 adrenoceptor antagonist in etorphine immobilised sheep (Ovis aries) - a randomised, prospective, and controlled trial.
    BMC Vet Res. 2026;22:224.
    PubMed    
    Abstract available
    
    

50. GIANI M, Bombino M, Ravasi M, Fumagalli B, et al
    Early trajectories of pulmonary hemodynamics in ARDS patients undergoing V-V ECMO: key determinants and prognostic impact.
    Crit Care. 2026;30:156.
    PubMed    
    Abstract available
    
    

51. REPSOLD L, Harutyunova S, Grunig E, Benjamin N, et al
    Reduced gastrointestinal iron uptake in pulmonary arterial hypertension: a prospective cross-sectional study.
    Respir Res. 2026;27:159.
    PubMed    
    Abstract available
    
    

52. CATON T, Pescatore J, Naranjo M, Gayen S, et al
    Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance.
    BMC Pulm Med. 2026;26:154.
    PubMed    
    Abstract available
    
    

53. AUEYINGSAK S, Khankaew K, Teerawattananant W, Singsangtam P, et al
    Validity and reliability testing of the Thai version of the emPHasis-10 questionnaire for patients with pulmonary arterial hypertension.
    J Patient Rep Outcomes. 2026;10:30.
    PubMed    
    Abstract available
    
    

54. WU R, Wang K, Fan M, Jia R, et al
    Multi-omics integration study of vascular smooth muscle cell phenotypic conversion identified novel biomarkers in idiopathic pulmonary arterial hypertension.
    Respir Res. 2026;27:135.
    PubMed    
    Abstract available
    
    

55. BAI HJ, Wang YW, Li ZQ, Lu DX, et al
    Perillyl alcohol attenuates hypoxia induced right ventricular dysfunction and remodeling by balancing the renin angiotensin aldosterone system in rats.
    Sci Rep. 2026;16:5417.
    PubMed    
    Abstract available
    
    

56. CHEN W, Luo X, Luo J, Song J, et al
    Clinical relevance of the TAPSE/SPAP ratio in pulmonary arterial hypertension: a single-center retrospective study.
    BMC Cardiovasc Disord. 2026;26:190.
    PubMed    
    Abstract available
    
    

57. BILGIC S, Vardaloglu I, Koroglu I, Karayel E, et al
    Perfusion-only Q-SPECT as a rule-out tool for CTEPH in resource-limited settings: a feasibility study on reducing unnecessary referrals to tertiary centers.
    BMC Pulm Med. 2026;26:72.
    PubMed    
    Abstract available
    
    

58. KUNSTYR J, Niznansky M, Prskavec T, Votruba J, et al
    Management of airway hemorrhage with endobronchial valve in patients undergoing pulmonary endarterectomy- an expert center experience: a case report.
    BMC Anesthesiol. 2026;26:124.
    PubMed    
    Abstract available
    
    

59. JINZHONG H, Chenxi L, Xiaojun L, Chengying H, et al
    Extracorporeal membrane oxygenation for pulmonary arterial hypertension complicating pregnancy: case series and literature review.
    BMC Pregnancy Childbirth. 2026;26:148.
    PubMed    
    Abstract available
    
    

60. TAMURA Y, Kumamaru H, Murakami K, Matsuoka K, et al
    Real-world treatment practices of selexipag and parenteral prostacyclin (PGI(2)) analogs for pulmonary arterial hypertension in Japan: Retrospective study of the Japan PH Registry.
    J Cardiol. 2026;88:29-37.
    PubMed    
    Abstract available
    
    

61. LUPPINO-ASSAD AP, Vidaurre R, Camata O, Miossi R, et al
    Impact of male sex in clinical and laboratory features of systemic sclerosis.
    Adv Rheumatol. 2026;66:12.
    PubMed    
    Abstract available
    
    

62. WU Y, Qian Y, Quan R, Yang Y, et al
    Ten-year survival, trends and risk stratification of newly diagnosed idiopathic pulmonary arterial hypertension in China: insights from a national multicenter prospective registry.
    BMC Pulm Med. 2025;25:547.
    PubMed    
    Abstract available
    
    

63. CHEN G, Zhang Q, Geng L, Zhang Y, et al
    Risk factors of incident lung diseases and the impact of DMARDs in rheumatoid arthritis patients: a longitudinal study.
    BMC Pulm Med. 2025;25:504.
    PubMed    
    Abstract available
    
    

64. KURIYAMA S, Iwamura C, Kiuchi M, Nagaoka T, et al
    Hypoxia-Induced Epas1-Myl9/12 Axis Shapes the Pathology of Pulmonary Hypertension.
    Circ Res. 2026 Jul 2. doi: 10.1161/CIRCRESAHA.125.327791.
    PubMed    
    Abstract available
    
    

65. KARNES JH, Bao C, Liang S, Thayer T, et al
    Variation in SNX29 and Acute Vasodilator Response in Pulmonary Arterial Hypertension.
    Circ Res. 2026;139:e327117.
    PubMed    
    Abstract available
    
    

66. NOSSENT EJ, Vonk Noordegraaf A
    Low diffusion capacity in pulmonary hypertension.
    Curr Opin Pulm Med. 2026 Jul 2. doi: 10.1097/MCP.0000000000001290.
    PubMed    
    Abstract available
    
    

67. DIAMOND S, Spray B, Qasim A, Mourani PM, et al
    Novel echocardiographic markers for the assessment of pulmonary hypertension in infants.
    J Perinatol. 2026 Jun 29. doi: 10.1038/s41372-026-02748.
    PubMed    
    Abstract available
    
    

68. DIAMOND SE, Stanford AH, Bischoff AR, McNamara PJ, et al
    Phenotype-based screening algorithm for chronic pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
    J Perinatol. 2026 Jun 29. doi: 10.1038/s41372-026-02776.
    PubMed    
    Abstract available
    
    

69. UENO K, Kelley D, Tashima T, Dominic J, et al
    Outcomes of donation after circulatory death heart transplantation in recipients with pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2026 Jun 27:S0022-5223(26)00887.
    PubMed    
    Abstract available